Skip to main content
JINLING PHARMACEUTICAL CO.,LTD logo

JINLING PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000919 ISIN · CNE0000010W5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,771 across all filing types
Latest filing 2017-06-06 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000919

About JINLING PHARMACEUTICAL CO.,LTD

https://www.jlyy1999.com

Jinling Pharmaceutical Co., Ltd. specializes in the research, development, manufacture, and sale of pharmaceutical products, with a focus on chemical drugs and traditional Chinese medicine preparations. The company’s product portfolio primarily targets cardiovascular and cerebrovascular diseases, anti-tumor treatments, and digestive system health. A prominent product in its lineup is the Mailuoning Injection, utilized for treating various vascular conditions. In addition to its manufacturing operations, the company is involved in the management and operation of medical institutions, integrating clinical services with pharmaceutical production. Its business model emphasizes the synergy between drug development and healthcare service delivery to provide integrated medical solutions.

Recent filings

Filing Released Lang Actions
独立董事提名人声明（二）
Board/Management Information Classification · 95% confidence The document is a public statement by a nominator regarding the nomination of an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report summaries. The content is related to board/management information, specifically about a board member nomination. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (5721 characters) supports it being a full statement rather than a brief announcement.
2017-06-06 Chinese
独立董事提名人声明（一）
Board/Management Information Classification · 95% confidence The document is a public statement from a nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and declarations about the nominee's independence and eligibility. There is no financial data, no report of financial results, no voting results, no legal proceedings, no capital changes, and no meeting materials. The document is an announcement related to board/management information, specifically about a nomination for a board position. Therefore, it fits best under the category of Board/Management Information (MANG). The document length (5721 characters) supports it being a full announcement rather than a brief notice or a report publication announcement.
2017-06-06 Chinese
第六届监事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the 17th meeting of the 6th Supervisory Board of Jinling Pharmaceutical Co., Ltd. It details the nomination of candidates for the 7th Supervisory Board, including their biographies and voting results. The content focuses on board/management changes and nominations rather than financial data or report publication. The document length is short (2130 characters) and it is clearly a formal announcement of board-related decisions. Therefore, it fits best under the category of Board/Management Information (MANG).
2017-06-06 Chinese
独立董事候选人声明（冯巧根）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of a company, detailing compliance with various legal and regulatory requirements for serving as an independent director. It includes statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no discussion of company performance, no voting results, no management changes, and no mention of any report publication. The content is focused on governance and compliance related to board membership. Therefore, this document fits best under Board/Management Information (MANG), as it relates to the announcement and declaration of a board member candidate's qualifications and independence.
2017-06-06 Chinese
第六届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 16th meeting of the 6th Board of Directors of Jinling Pharmaceutical Co., Ltd. It details the nomination of candidates for the 7th Board of Directors, voting results, and procedural compliance. The content focuses on board member nominations and election procedures, including candidate biographies and voting outcomes. There is no financial data, earnings information, or audit content. The document is not a report itself but an official announcement of board decisions and management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is 4521 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is MANG with high confidence.
2017-06-06 Chinese
关于召开2016年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2016 Annual General Meeting (AGM) of Jinling Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures, proposals to be discussed and voted on, including election of directors and auditors, and instructions for shareholders on how to participate and vote. The document does not contain financial statements or detailed financial analysis but rather serves as an official announcement and procedural guide for the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length (9353 characters) is consistent with a full AGM notice rather than a brief announcement or proxy statement.
2017-06-06 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.